Revelation Biosciences
REVB
8 hedge funds and large institutions have $540K invested in Revelation Biosciences in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
740% more capital invested
Capital invested by funds: $64.2K → $540K (+$476K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
14% more funds holding
Funds holding: 7 → 8 (+1)
3.33% more ownership
Funds ownership: 0.74% → 4.06% (+3.3%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$449K |
| 2 |
AC
Armistice Capital
New York
|
+$194K |
| 3 |
DS
DRW Securities
Chicago,
Illinois
|
+$188K |
| 4 |
Jane Street
New York
|
+$35.8K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$29 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG
StoneX Group
New York
|
-$7.66K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.51K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$602 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$10 |
REVB Hedge Fund Activity: Q3 2025 in Review
8 of the 7,624 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences (REVB) for Q3 2025, worth a combined $540K — up 740% from $64.2K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new REVB positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Sabby Management, adding an estimated $449K. The largest seller was StoneX Group, exiting entirely with an estimated $7.66K sold.
- 8 institutional investors held Revelation Biosciences (REVB) as of Q3 2025, up from 7 in Q2 2025.
- Funds reported $540K of Revelation Biosciences stock for Q3 2025, up 740% quarter-over-quarter.
- 3 funds opened new Revelation Biosciences positions in Q3 2025 and 2 closed out, a net change of +1 holder.
- The largest Revelation Biosciences buyer in Q3 2025 was Sabby Management, an estimated $449K added.
- The largest Revelation Biosciences seller in Q3 2025 was StoneX Group, an estimated $7.66K sold.
Based on aggregated 13F filings for Q3 2025.